Development of Improved Mumps Vaccine Candidates by Mutating Viral mRNA Cap Methyltransferase Sites in the Large Polymerase Protein

Albertson JP, Clegg WJ, Reid HD, Arbise BS, Pryde J, Vaid A, Thompson-Brown R, Echols F (2016) Mumps Outbreak at a University and Recommendation for a Third Dose of Measles-Mumps-Rubella Vaccine - Illinois, 2015–2016. MMWR Morb Mortal Wkly Rep 65:731–734 Beleni AI, Borgmann S (2018) Mumps in the vaccination age: global epidemiology and the situation in Germany. Int J Environ Res Public Health 15:1618 Boukhvalova MS, Blanco JC (2013) The cotton rat Sigmodon hispidus model of respiratory syncytial virus infection. Curr Top Microbiol Immunol 372:347–358 Bukreyev A, Camargo E, Collins PL (1996) Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene. J Virol 70:6634–6641 Buynak EB, Hilleman MR (1966) Live attenuated mumps virus vaccine. 1. Vaccine development. Proc Soc Exp Biol Med 123:768–775 Cardemil CV, Dahl RM, James L, Wannemuehler K, Gary HE, Shah M, Marin M, Riley J, Feikin DR, Patel M, Quinlisk P (2017) Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control. N Engl J Med 377:947–956 Clarke DK, Sidhu MS, Johnson JE, Udem SA (2000) Rescue of mumps virus from cDNA. J Virol 74:4831–4838 Cui A, Zhu Z, Hu Y, Deng X, Sun Z, Zhang Y, Mao N, Xu S, Fang X, Gao H, Si Y, Lei Y, Zheng H, He J, Wu H, Xu W (2017) Mumps Epidemiology and Mumps Virus Genotypes Circulating in Mainland China during 2013–2015. PLoS ONE 12:e0169561 Cui A, Zhu Z, Mao N, Si Y, Ma Y, Hu Y, Deng X, Wang L, Zeng L, Zhang Y, Xu W (2018) Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China. Vaccine 36:5725–5731 Cusi MG, Correale P, Valassina M, Sabatino M, Valensin PE, Donati M, Gluck R (2001) Comparative study of the immune response in mice immunized with four live attenuated strains of mumps virus by intranasal or intramuscular route. Arch Virol 146:1241–1248 Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J, Lin TY, Schneller S, Zust R, Dong H, Thiel V, Sen GC, Fensterl V, Klimstra WB, Pierson TC, Buller RM, Gale M Jr, Shi PY, Diamond MS (2010) 2’-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468:452–456 Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V (2020) Vaccines for measles, mumps, rubella and varicella in children. Cochrane Database Syst Rev 4:004407 Elango N, Varsanyi TM, Kovamees J, Norrby E (1988) Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus. J Gen Virol 69:2893–2900 Elliott GD, Yeo RP, Afzal MA, Simpson EJ, Curran JA, Rima BK (1990) Strain-variable editing during transcription of the P gene of mumps virus may lead to the generation of non-structural proteins NS1 (V) and NS2. J Gen Virol 71:1555–1560 Fields VS, Safi H, Waters C, Dillaha J, Capelle L, Riklon S, Wheeler JG, Haselow DT (2019) Mumps in a highly vaccinated Marshallese community in Arkansas, USA: an outbreak report. Lancet Infect Dis 19:185–192 Galazka AM, Robertson SE, Kraigher A (1999) Mumps and mumps vaccine: a global review. Bull World Health Organ 77:3–14 Garcin D, Pelet T, Calain P, Roux L, Curran J, Kolakofsky D (1995) A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J 14:6087–6094 Ge P, Tsao J, Schein S, Green TJ, Luo M, Zhou ZH (2010) Cryo-EM model of the bullet-shaped vesicular stomatitis virus. Science 327:689–693 Gilman MSA, Liu C, Fung A, Behera I, Jordan P, Rigaux P, Ysebaert N, Tcherniuk S, Sourimant J, Eleouet JF, Sutto-Ortiz P, Decroly E, Roymans D, Jin Z, McLellan JS (2019) Structure of the respiratory syncytial virus polymerase complex. Cell 179:193–204 Green MG, Huey D, Niewiesk S (2013) The cotton rat (Sigmodon hispidus) as an animal model for respiratory tract infections with human pathogens. Lab Anim (NY) 42:170–176 Jin H, Clarke D, Zhou HZ, Cheng X, Coelingh K, Bryant M, Li S (1998) Recombinant human respiratory syncytial virus (RSV) from cDNA and construction of subgroup A and B chimeric RSV. Virology 251:206–214 Kristensson K, Orvell C, Malm G, Norrby E (1984) Mumps virus infection of the developing mouse brain–appearance of structural virus proteins demonstrated with monoclonal antibodies. J Neuropathol Exp Neurol 43:131–140 Lawson ND, Stillman EA, Whitt MA, Rose JK (1995) Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci U S A 92:4477–4481 Lewnard JA, Grad YH (2018) Vaccine waning and mumps re-emergence in the United States. Sci Transl Med 10:5945 Li J, Wang JT, Whelan SP (2006) A unique strategy for mRNA cap methylation used by vesicular stomatitis virus. Proc Natl Acad Sci U S A 103:8493–8498 Liang Y, Ma S, Liu L, Zhao H, Wang L, Jiang L, Xie Z, Dong C, Li Q (2010) Identification and development of a promising novel mumps vaccine candidate strain. Microbes Infect 12:1178–1187 Ma C, Liu Y, Tang J, Jia H, Qin W, Su Y, Wang H, Hao L (2018) Assessment of mumps-containing vaccine effectiveness during an outbreak: Importance to introduce the 2-dose schedule for China. Hum Vaccin Immunother 14:1392–1397 Ma R, Lu L, Zhou T, Pan J, Chen M, Pang X (2018) Mumps disease in Beijing in the era of two-dose vaccination policy, 2005–2016. Vaccine 36:2589–2595 Ma Y, Wei Y, Zhang X, Zhang Y, Cai H, Zhu Y, Shilo K, Oglesbee M, Krakowka S, Whelan SP, Li J (2014) mRNA cap methylation influences pathogenesis of vesicular stomatitis virus in vivo. J Virol 88:2913–2926 Marin M, Marlow M, Moore KL, Patel M (2018) Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak. MMWR Morb Mortal Wkly Rep 67:33–38 May M, Rieder CA, Rowe RJ (2018) Emergent lineages of mumps virus suggest the need for a polyvalent vaccine. Int J Infect Dis 66:1–4 Muhlemann K (2004) The molecular epidemiology of mumps virus. Infect Genet Evol 4:215–219 Muthukrishnan S, Morgan M, Banerjee AK, Shatkin AJ (1976) Influence of 5’-terminal m7G and 2’–O-methylated residues on messenger ribonucleic acid binding to ribosomes. Biochemistry 15:5761–5768 Nogales A, Martinez-Sobrido L (2016) Reverse genetics approaches for the development of influenza vaccines. Int J Mol Sci 18:20 Pang H, Zhou Y, Zhao W, Jiang Q (2018) Seroprevalence and determinants associated with mumps antibodies after 20 Years of MMR vaccination in urban area of Shanghai. Int J Environ Res Public Health 15:2089 Parker L, Gilliland SM, Minor P, Schepelmann S (2013) Assessment of the ferret as an in vivo model for mumps virus infection. J Gen Virol 94:1200–1205 Pickar A, Xu P, Elson A, Zengel J, Sauder C, Rubin S, He B (2017) Establishing a small animal model for evaluating protective immunity against mumps virus. PLoS ONE 12:e0174444 Poch O, Blumberg BM, Bougueleret L, Tordo N (1990) Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains. J Gen Virol 71:1153–1162 Rubin S, Eckhaus M, Rennick LJ, Bamford CG, Duprex WP (2015) Molecular biology, pathogenesis and pathology of mumps virus. J Pathol 235:242–252 Rubin SA, Snoy PJ, Wright KE, Brown EG, Reeve P, Beeler JA, Carbone KM (1999) The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains. J Infect Dis 180:521–525 Saika S, Kidokoro M, Kubonoya H, Ito K, Ohkawa T, Aoki A, Nagata N, Suzuki K (2006) Development and biological properties of a new live attenuated mumps vaccine. Comp Immunol Microbiol Infect Dis 29:89–99 Su M, Mao Y, Shi TC, Liao W, Xu XF (2014) Evaluation of the neurovirulence of the strain s79 working seed lot of live attenuated mumps vaccines in rhesus monkeys. Chinese Journal of New Drugs 23:1267–1272 Sun J, Wei Y, Rauf A, Zhang Y, Ma Y, Zhang X, Shilo K, Yu Q, Saif YM, Lu X, Yu L, Li J (2014) Methyltransferase-defective avian metapneumovirus vaccines provide complete protection against challenge with the homologous Colorado strain and the heterologous Minnesota strain. J Virol 88:12348–12363 Tsurudome M, Yamada A, Hishiyama M, Ito Y (1987) Replication of mumps virus in mouse: transient replication in lung and potential of systemic infection. Arch Virol 97:167–179 Wang Y, Liu R, Lu M, Yang Y, Zhou D, Hao X, Zhou D, Wang B, Li J, Huang YW, Zhao Z (2018) Enhancement of safety and immunogenicity of the Chinese Hu191 measles virus vaccine by alteration of the S-adenosylmethionine (SAM) binding site in the large polymerase protein. Virology 518:210–220 Westphal DW, Eastwood A, Levy A, Davies J, Huppatz C, Gilles M, Lyttle H, Williams SA, Dowse GK (2019) A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study. Lancet Infect Dis 19:177–184 Whelan SP, Barr JN, Wertz GW (2004) Transcription and replication of nonsegmented negative-strand RNA viruses. Curr Top Microbiol Immunol 283:61–119 Wolinsky JS, Klassen T, Baringer JR (1976) Persistence of neuroadapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation. J Infect Dis 133:260–267 Wu L, Bai Z, Li Y, Rima BK, Afzal MA (1998) Wild type mumps viruses circulating in China establish a new genotype. Vaccine 16:281–285 Wu L, Hu J, Li Z, Yang J, Sun X (2018) Epidemiology of mumps in Shanghai, 1990–2015. Chin J Vaccines Immun 024:43–47 Xu P, Chen Z, Phan S, Pickar A, He B (2014) Immunogenicity of novel mumps vaccine candidates generated by genetic modification. J Virol 88:2600–2610 Xu P, Li Z, Sun D, Lin Y, Wu J, Rota PA, He B (2011) Rescue of wild-type mumps virus from a strain associated with recent outbreaks helps to define the role of the SH ORF in the pathogenesis of mumps virus. Virology 417:126–136 Yang YT, Chow YH, Hsiao KN, Hu KC, Chiang JR, Wu SC, Chong P, Liu CC (2016) Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology. Antiviral Res 132:225–232 Zengel J, Phan SI, Pickar A, Xu P, He B (2017) Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China. Vaccine 35:3988–3994 Zhang Y, Wei Y, Zhang X, Cai H, Niewiesk S, Li J (2014) Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase. J Virol 88:11411–11429 Zhou D, Zhu MY, Wang YL, Hao XQ, Zhou DM, Liu RX, Zhang CD, Qu CF, Zhao ZY (2019a) Attenuated MuV-S79 as vector stably expressing foreign gene. World J Pediatr 15:511–515 Zhou D, Zhu MY, Wang YL, Hao XQ, Zhou DM, Liu RX, Zhang CD, Qu CF, Zhao ZY (2019b) Establishment of an efficient reverse genetic system of Mumps virus S79 from cloned DNA. World J Pediatr 15:499–505 Zust R, Cervantes-Barragan L, Habjan M, Maier R, Neuman BW, Ziebuhr J, Szretter KJ, Baker SC, Barchet W, Diamond MS, Siddell SG, Ludewig B, Thiel V (2011) Ribose 2’-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol 12:137–143